2021
Leveraging a health information exchange for analyses of COVID-19 outcomes including an example application using smoking history and mortality
Tortolero G, Brown M, Sharma S, de Oliveira Otto M, Yamal J, Aguilar D, Gunther M, Mofleh D, Harris R, John J, de Vries P, Ramphul R, Serbo D, Kiger J, Banerjee D, Bonvino N, Merchant A, Clifford W, Mikhail J, Xu H, Murphy R, Wei Q, Vahidy F, Morrison A, Boerwinkle E. Leveraging a health information exchange for analyses of COVID-19 outcomes including an example application using smoking history and mortality. PLOS ONE 2021, 16: e0247235. PMID: 34081724, PMCID: PMC8174716, DOI: 10.1371/journal.pone.0247235.Peer-Reviewed Original ResearchConceptsBody mass indexCOVID-19 patientsRisk factorsTobacco useCOVID-19 fatalitiesHealth information exchangeRace/ethnicityCOVID-19Laboratory risk factorsNumber of comorbiditiesCOVID-19 cohortMultivariable logistic regressionImportant risk factorPotential risk factorsCOVID-19 outcomesFormer tobacco usersTobacco use historyLarge health information exchangeMass indexElectronic health record systemsUnfavorable outcomeClinical dataTobacco usersOutcome analysisElectronic health information
2014
Genotype and risk of major bleeding during warfarin treatment
Kawai V, Cunningham A, Vear S, Van Driest S, Oginni A, Xu H, Jiang M, Li C, Denny J, Shaffer C, Bowton E, Gage B, Ray W, Roden D, Stein C. Genotype and risk of major bleeding during warfarin treatment. Pharmacogenomics 2014, 15: 1973-1983. PMID: 25521356, PMCID: PMC4304738, DOI: 10.2217/pgs.14.153.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedBiological Specimen BanksCytochrome P-450 CYP2C9Cytochrome P-450 Enzyme SystemCytochrome P450 Family 4Dose-Response Relationship, DrugEthnicityFemaleGene FrequencyGenetic Association StudiesGenetic VariationGenotypeHemorrhageHumansMaleMiddle AgedRisk FactorsVitamin K Epoxide ReductasesWarfarin